281: Cancer, Covid, And Medical Blindspots - with Dr. Peter McCullough

2026-06-19

Download

The conversation centers around newly reported findings involving the use of ivermectin and mebendazole in cancer patients. Dr. McCullough explains how observational data collected through The Wellness Company and the McCullough Foundation showed an 84% positive response signal among participants, including cases of remission, disease stabilization, and reductions in tumor burden. He discusses the biological mechanisms being investigated, including effects on cancer cell proliferation, blood supply, and apoptosis. Beyond cancer treatment, Josh and Dr. McCullough explore the broader epidemic of chronic illness. They examine the dramatic rise in inflammatory bowel...

Beyond cancer treatment, Josh and Dr. McCullough explore the broader epidemic of chronic illness. They examine the dramatic rise in inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, the role of environmental exposures, immune dysregulation, microbiome disruption, and the growing evidence that many chronic conditions may be driven by root-cause factors rather than purely genetic predisposition.

If you're interested in gut health, inflammation, the microbiome, immune function, cancer prevention, or root-cause medicine, this episode offers a thought-provoking look at some of the most important health conversations happening today.

TOPICS DISCUSSED: